Colipse Coffee Expands Its Swiss Water® Decaf Line with New Sizes and Grind Options
'Decaf is no longer just a side option. Our customers want the same richness and complexity they get from regular coffee so we revisited the roast and built a lineup that stands on its own.'— Michal Sieroslawski, founder of Colipse Coffee
BOSTON, MA, UNITED STATES, July 27, 2025 / EINPresswire.com / -- Colipse Coffee, a specialty coffee brand that has seen 200% growth in decaf coffee sales over the past year, today announced a comprehensive expansion of its Swiss Water® Process decaf collection. The upgrade introduces four bag sizes, four grind options, and bulk pricing that saves customers up to 40% per ounce.
The decaf market is growing steadily as consumers increasingly prioritize sleep quality, anxiety management, and caffeine control for medical conditions. Pregnant women, medication users, and those with digestive sensitivities are driving demand for high-quality decaf that doesn't sacrifice taste. Unlike traditional chemical methods using methylene chloride or ethyl acetate, Colipse's Swiss Water® process removes 99.9% of caffeine using only water, temperature, and time – making it increasingly valuable to health-conscious consumers.
The numbers reflect this shift: the global decaffeinated coffee market reached $2.39 billion in 2024 and is projected to grow at 7.2% annually through 2035, significantly outpacing traditional coffee. The National Coffee Association reports 7% of Americans now consume decaf daily, with strongest growth among health-focused consumers aged 40 and over.
Product Expansion Details
Bag Sizes: Now offered in 12 oz, 16 oz, 2 lb, and 5 lb formats for all Colipse Swiss Water decaf coffees
Grind Options: Available as whole bean, coarse (for French press & cold brew), medium (for drip), and fine (for espresso & moka)
Bulk Savings: Customers can save up to 40% per ounce with larger 5 lb bags
Flexible Subscriptions: Choose grind type, bag size, delivery schedule, and pause or skip anytime
The expanded line works seamlessly with popular equipment including Jura, De'Longhi, Breville, and Gaggia machines, plus manual methods like Chemex, Hario V60, and French press. Each order is roasted fresh, vacuum-sealed for peak flavor retention, and ships free across the United States. The expanded Swiss Water® decaf line is available immediately at colipsecoffee.com with introductory pricing starting at $21.95 for 12 oz bags. Bulk discounts apply automatically, and subscription customers receive an additional 5% off all orders.
'I was looking for the cleanest and best decaf coffee on the market and I think I found it,' said Charlotte Anderson, a Colipse customer. 'This coffee is delicious - my stomach can't handle caffeine, but I don't have to sacrifice taste.'
About Colipse Coffee
Founded in 2024, Colipse Coffee is a New Mexico-based specialty coffee company committed to delivering exceptional coffee through sustainable practices and innovative processing methods. The company has experienced rapid growth by focusing on quality, freshness, and customer service.
Michal Sieroslawski
Colipse Coffee
+1 505-445-3781
email us here
Visit us on social media:
X
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
China welcomes 183 Brazil coffee sellers in wake of US tariffs
By Ana Mano SAO PAULO (Reuters) -China has approved 183 new Brazilian coffee companies to export products to the Chinese market, according to a social media post of the Chinese embassy in Brazil on Saturday. The measure, a boon to local exporters after the United States government's announcement of steep tariffs on Brazilian coffee and other products, took effect on July 30. The new Chinese export permits are valid for five years, according to the post. The U.S.'s 50% tariff on some Brazilian products will begin on August 6. The levy represents a challenge for commodities traders and Brazilian coffee exporters, who need to find alternatives for the roughly 8 million bags sold to U.S. coffee processors every year. China is Brazil's top trade partner overall while the U.S. is a big buyer of Brazilian beef and orange juice, among other products. In June, Brazilian coffee exports into the U.S. totaled 440,034 60-kilo bags, 7,87 times more than Brazil's sales into China of nearly 56,000 bags that month, according to trade data compiled by industry lobby Cecafe. The Brazilian ministry of agriculture and Cecafe did not have an immediate comment. China's customs authority could not be immediately reached as it was outside the business hours. Brazil supplies about a third of the U.S. coffee demand each year, a trade valued at $4.4 billion in the 12 months ended in June. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
What To Expect From Vertex Pharmaceuticals's (VRTX) Q2 Earnings
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here's what to look for. Vertex Pharmaceuticals missed analysts' revenue expectations by 2.3% last quarter, reporting revenues of $2.77 billion, up 3% year on year. It was a disappointing quarter for the company, with a significant miss of analysts' EPS estimates and full-year revenue guidance slightly missing analysts' expectations. Is Vertex Pharmaceuticals a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Vertex Pharmaceuticals's revenue to grow 9.8% year on year to $2.90 billion, improving from the 6.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $4.25 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Vertex Pharmaceuticals has missed Wall Street's revenue estimates three times over the last two years. Looking at Vertex Pharmaceuticals's peers in the therapeutics segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Biogen delivered year-on-year revenue growth of 7.3%, beating analysts' expectations by 13.7%, and Moderna reported a revenue decline of 41.1%, topping estimates by 10.7%. Biogen traded up 3.9% following the results. Read our full analysis of Biogen's results here and Moderna's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the therapeutics stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Vertex Pharmaceuticals's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $505.19 (compared to the current share price of $464). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
China welcomes 183 Brazil coffee sellers in wake of US tariffs
By Ana Mano SAO PAULO (Reuters) -China has approved 183 new Brazilian coffee companies to export products to the Chinese market, according to a social media post of the Chinese embassy in Brazil on Saturday. The measure, a boon to local exporters after the United States government's announcement of steep tariffs on Brazilian coffee and other products, took effect on July 30. The new Chinese export permits are valid for five years, according to the post. The U.S.'s 50% tariff on some Brazilian products will begin on August 6. The levy represents a challenge for commodities traders and Brazilian coffee exporters, who need to find alternatives for the roughly 8 million bags sold to U.S. coffee processors every year. China is Brazil's top trade partner overall while the U.S. is a big buyer of Brazilian beef and orange juice, among other products. In June, Brazilian coffee exports into the U.S. totaled 440,034 60-kilo bags, 7,87 times more than Brazil's sales into China of nearly 56,000 bags that month, according to trade data compiled by industry lobby Cecafe. The Brazilian ministry of agriculture and Cecafe did not have an immediate comment. China's customs authority could not be immediately reached as it was outside the business hours. Brazil supplies about a third of the U.S. coffee demand each year, a trade valued at $4.4 billion in the 12 months ended in June. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
